Amino Acid Substitution in Hepatitis C Virus Core and Genetic Variation in Interleukin 28? Gene and their Correlation to Interferon Treatment Failure in Chronic HCV Egyptian Patients

Nashwa El-Khazragy, Maiada A. Hussien, Mohamed A. El-Mordy, Amany M. Maher

Abstract: Hepatitis C virus becomes a one of the top curable chronic diseases worldwide, this was referred to the remarkable efficacy of antiviral therapy, however, many cases showed resistance to interferon/Ribavirin combination therapy. Genetic polymorphism is the major cause of relapse after therapy. To determine whether Hepatitis C virus (HCV) core substitution and IL-28 (rs8099917) play a role in the response to INF/RBV antiviral therapy, 115 HCV chronically infected patients initiated treatment with Peglated INF plus ribavirin (INF/RBV) for 48 weeks were tested for baseline substitution at codon 70 of the viral core protein and for genetic polymorphism in IL-28 rs8099917 (TaqMan Probe assay, Applied Biosystems). In this study, we observed that, TT genotype in IL-28 polymorphism was the favourable genotype as 75 % of this genotype achieved therapeutic success, defined as sustained viral response at 12 weeks of therapy.23.5 % of studied patients presented a mutant HCV core substitution at core position 70, those were resistant to therapy and failed to achieve a viral response. A multivariate analysis revealed three independent predictors of therapeutic success age40years (P

Keywords: Hepatitis C virus, IL-28 rs8099917, INF/RBV antiviral therapy, HCV core substitution

How to Cite?: Nashwa El-Khazragy, Maiada A. Hussien, Mohamed A. El-Mordy, Amany M. Maher, "Amino Acid Substitution in Hepatitis C Virus Core and Genetic Variation in Interleukin 28? Gene and their Correlation to Interferon Treatment Failure in Chronic HCV Egyptian Patients", Volume 6 Issue 5, May 2017, International Journal of Science and Research (IJSR), Pages: 1187-1192, https://www.ijsr.net/getabstract.php?paperid=ART20173368, DOI: https://dx.doi.org/10.21275/ART20173368

Download Citation: APA | MLA | BibTeX | EndNote | RefMan